FINWIRES · TerminalLIVE
FINWIRES

Entrada Therapeutics Insider Sold Shares Worth $807,027, According to a Recent SEC Filing

By

Kush Parmar, 10% Owner, Director, on July 30, 2026, sold 116,474 shares in Entrada Therapeutics (TRDA) for $807,027. Following the Form 4 filing with the SEC, Parmar has control over a total of 3,939,905 common shares of the company, with 3,939,905 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1689375/000166428126000002/xslF345X05/form4-08032026_090837.xml

Related Articles